Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
ESSA Pharma Inc. (EPIX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/26/2021 |
4/A
| ZWEIFACH SANFORD S (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Thorell Marella (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Sollis Gary (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Requadt Scott (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Martin John Alexander (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| Glickman Richard M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 25,000 options to buy
@ $7, valued at
$175k
|
|
| 01/26/2021 |
4/A
| Brettman Ari David (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
| 01/26/2021 |
4/A
| BERGER FRANKLIN M (Director) has filed a Form 4 on ESSA Pharma Inc.|
Txns:
| Granted 16,500 options to buy
@ $7, valued at
$115.5k
|
|
|
|